lundi 29 janvier 2018

Onco Actu du 29 janvier 2018

1. Biologie

What Good Is Crispr if It Can't Get Where It Needs to Go? [Wired]

2.7 Etiologie - Obésité

Obese Men May Have Higher Chance of Recurrence Following Radical [AACR]

Quality of Children’s Sleep May Affect Eating Habits and Weight [AACR]

Predicted Rise in Canadian Obesity Rate May Lead to Higher Cancer Burden [AACR]

High Body Fat Levels Are Associated With Increased Breast Cancer Risk in Postmenopausal Women With Normal BMI [AACR]

4.2 Dép., diag. & prono. - Génome

Should Everyone Have Their Whole Genome Sequenced at Birth? [Front Line Genomics]

5. Traitements

Study Identifies Potential Cause of Hearing Loss from Cisplatin [NCI]

5.10 Traitements - Essais

Rethinking clinical trials – how Tessa Jowell’s intervention could benefit people with cancer [Institute of Cancer Research]

Tessa Jowell is right about cancer treatment: Britain must do better [The Guardian]

5.12.9 Immunothérapies - SITC

CAR T-Cell Therapy is Well Tolerated With Promising Efficacy in High-Risk NHL [ASCO-SITC]

5.2.2 Pharma - Fusions & Acquisitions

Sanofi to acquire Ablynx for €3.9 Billion [Sanofi]

5.2.3 Pharma - économie

Biopharma veterans go in on oncology company that will tackle treatment gaps [FierceBiotech]

Ex-Merrimack CEO Mulroy launches oncology startup Partner Therapeutics [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA,...)

Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors [Novartis]

Novartis wins FDA nod for newly acquired cancer drug Lutathera [FiercePharma]

FDA approves new treatment for certain digestive tract cancers [FDA]

Novartis scores a quick FDA OK for its new cancer drug Lutathera, picked up in $4B buyout [EndPoints]

FDA clears radioactive drug for cancer that killed Steve Jobs [Reuters]

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 January 2018 [EMA]

5.4 Traitements - Economie

NICE Issues Technology Appraisal Guidance on Lenvatinib with Everolimus for Previously Treated Advanced RCC [ESMO]

Professor Carole Longson MBE appointed Chief Scientific Officer at the ABPI [ABPI]

Among those who want to lower drug prices, there’s cacophony, not consensus [STAT]

5.5 ASCO

Astellas to Present New Oncology Data at the 2018 ASCO Genitourinary Cancers (GU) Symposium [Astellas]

6. Lutte contre les cancers

Bright light therapy may help fatigued cancer survivors sleep better [Reuters]

6.10 Politiques

Computer scientist to lead French research giant; interim-head leaves amid misconduct allegations [Science]

6.11 Patients

I refuse to let cancer deprive my sons of their mother [The Guardian]

6.12 Ethique

Scientists Hate the NIH’s New Rules for Experimenting on Humans [Wired]

6.2 Implants mammaires

Breast implants tied to increased risk of rare blood cancer [Reuters]